Human Parvovirus B19 and Parvovirus Infection

Virology and Structure of Human Parvovirus B19

Parvovirus B19 is a small, non-enveloped, single-stranded DNA virus. It is approximately 25 nanometers in diameter and has a characteristic icosahedral capsid structure. The viral genome consists of a linear, single-stranded DNA molecule that encodes two main proteins: the non-structural protein (NS1) and the viral capsid protein (VP1/VP2).

Non-Structural Protein (NS1)

The NS1 protein is a multifunctional protein that is essential for viral replication and modulation of host immune responses. Here are some important characteristics and functions of NS1:

• Replication: NS1 plays a crucial role in viral replication by serving as a replication initiator or a cofactor for DNA replication. It binds to viral DNA and forms a complex with other viral and host proteins to facilitate the replication process.
• Transcriptional regulation: NS1 is involved in regulating viral gene expression. It interacts with host transcription factors and cellular proteins to modulate viral gene transcription, ensuring the production of necessary viral proteins during infection.
• Immune modulation: NS1 can interfere with the host immune response to facilitate viral replication and persistence. It modulates the production of pro-inflammatory cytokines and chemokines, suppresses the activation of immune cells, and evades host immune surveillance.
• Cytotoxicity: NS1 has been shown to induce cytotoxic effects in various cell types. It can cause apoptosis (programmed cell death) or necrosis, contributing to the tissue damage observed in some B19V-associated diseases.

Viral Capsid Protein (VP1/VP2)

The viral capsid protein is responsible for forming the outer shell or capsid of the B19V virion. It encapsulates the viral genome and protects it from degradation. Here are some key aspects of the viral capsid protein:

• Structure and composition: The viral capsid protein is synthesized as a precursor protein called VP1-VP2. Through post-translational modifications, VP1 and VP2 are generated. VP1 is the larger protein, while VP2 is a truncated version derived from VP1. These proteins assemble to form the icosahedral capsid structure of B19V.
• Host cell attachment and entry: The viral capsid protein mediates attachment to specific receptors on the surface of host cells, allowing the virus to enter and initiate infection. Globoside, a glycolipid receptor, has been identified as a primary receptor for B19V.
• Immunogenicity: The capsid protein is a major target for the host immune response. It induces the production of neutralizing antibodies, which can help control the infection and provide immunity against future exposures to B19V.
• Antigenic variability: The capsid protein displays antigenic variability, with different regions of the protein exhibiting variations among B19V strains. This variability contributes to the development of distinct B19V genotypes and subtypes.

Diagnosis of B19

• Diagnostic Cytopathology
  The presence of giant pronormoblasts in either the bone marrow (BM) or peripheral blood can indicate a possible infection with the B19 virus. However, it is important to note that the presence or absence of these cells should not be the sole basis for diagnosing B19 infection.
• Detection of B19 Virus
  Various methods can be used to detect the B19 virus, including electron microscopy (EM), enzyme-linked immunosorbent assays (ELISAs), and hemagglutination. However, the most common approach is the isolation of viral DNA using direct hybridization or polymerase chain reaction (PCR). Direct hybridization employs a labeled viral DNA probe to bind to DNA in clinical specimens, allowing for quantifiable results and detection of all known B19 variants. PCR has increased sensitivity but requires caution to avoid contamination. Detectable DNA levels can persist in serum, synovial membranes, and bone marrow, even in healthy individuals. Therefore, low levels of B19 DNA alone are insufficient to diagnose acute infection. Moreover, multiple primer pairs should be used to avoid missing B19 variants.
• Detection of Antibodies
  B19 DNA-based assays are crucial for diagnosing B19 infection in transient aplastic crisis and chronic infections in immunosuppressed individuals. In immunocompetent individuals with erythema infectiosum or B19-induced arthropathy, diagnosis relies on detecting B19-specific antibodies. Initially, viral capsids were purified from serum with high virus titers for antibody tests. B19 antigen can be expressed in bacteria, cell lines, or as peptides, but insect cell lines with recombinant baculovirus are commonly used to produce non-infectious recombinant antigens. Commercial assays depend on expressing capsid proteins as virus-like particles (VLP) in the baculovirus system, which efficiently produces VP1/VP2 and VP2 capsids.
  IgM capture assays are reliable for detecting current or recent infections, with more than 85% of patients exhibiting specific IgM antibodies. IgG detection can be done through capture assays or indirect assays, but IgG detection alone is generally not useful for diagnosing acute infections. The detection of NS1-specific antibodies has been debated, with some suggesting its association with an altered disease course or persistent infection, while others find no evidence of its significance.